Skip to main content

Sangamo Therapeutics, Inc 10-Q for FY2024 Q1

Sangamo Therapeutics, Inc (SGMOQ)

10-Q 2024-05-09 For: 2024-03-31
View Original
Added on April 10, 2026

About this 10-Q

Sangamo Therapeutics, Inc filed this 10-Q on May 9, 2024, covering the quarter ended March 31, 2024 (FY2024 Q1).

Headline figures

Quarter ended March 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$481K
down 99.7% from $157.96M a year earlier
Net loss
$49.09M
compared with net income of $21.13M a year earlier
Diluted EPS
-$0.27
compared with $0.12 a year earlier